Cue Biopharma, Inc.
CUE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001645460
In the last 90 days, Cue Biopharma, Inc. insiders filed 0 open-market purchases and 3 sales; 50 institutions reported holding it in 13F filings for Q2 2026, worth $52.2M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Cue Biopharma, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 50 | 55 | +5 |
| Shares | 13.9M | 11.8M | −2.15M (−15.5%) |
| Value | $10.5M | $12.8M | +$2.28M (+21.7%) |
New holders (12)
Institutions that held Cue Biopharma, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 49,055 | $53.0K | 0.00% |
| Texas Capital Bank Wealth Management Services Inc | 33,102 | $36.1K | 0.00% |
| Navalign, LLC | 25,000 | $27.3K | 0.01% |
| Squarepoint Ops LLC | 19,680 | $21.5K | 0.00% |
| Virtu Financial LLC | 16,829 | $18.0K | 0.00% |
| Susquehanna International Group, LLP | 13,258 | $14.5K | 0.00% |
| Cubist Systematic Strategies, LLC | 3,661 | $3.99K | 0.00% |
| Golden State Wealth Management, LLC | 2,000 | $2.18K | 0.00% |
| UMA Financial Services, Inc. | 1,006 | $1.10K | 0.00% |
| MAI Capital Management | 350 | $382 | 0.00% |
| Stonebridge Financial Group, LLC | 62 | $68 | 0.00% |
| SBI Securities Co., Ltd. | 1 | $1 | 0.00% |
Sold out (7)
Institutions that held Cue Biopharma, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Slate Path Capital LP | 2,402,455 | $1.82M |
| Qube Research & Technologies Ltd | 24,672 | $18.7K |
| Dimensional Fund Advisors LP | 14,575 | $10.9K |
| Legacy Capital Group California, Inc. | 10,000 | $7.57K |
| Catalyst Funds Management Pty Ltd | 9,000 | $6.81K |
| Harbour Investments, Inc. | 439 | $332 |
| SRS Capital Advisors, Inc. | 215 | $163 |